A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
BioSpace | The U.S. Congress typically pins the high cost of healthcare on the pharmaceutical industry, citing sometimes exorbitant prices for disease-modifying therapies. But drug prices are...
PINC AI™ Value-Based Care consulting experts break down all the details for eligible oncology practices and share benefits of participation.
PINC AI™ is narrowing the gaps in maternal and infant care through standardized and timely data.
Initiative builds on Premier and its members’ efforts to help ensure a more agile, transparent and robust U.S. healthcare supply chain
One database offers visibility into the maternal and infant relationship to support clinical research and medical solution development that can impact perinatal health.
Premier responds to CMS' proposed policies on the CY 2023 payment update, 340B, N95s and CDS.
We've got four actions CMS can take to help achieve their 2030 goal for accountable care arrangements.
FDA Public Workshop | Premier’s Soumi Saha was invited to participate in the workshop’s June 7 panel discussion: "Resilience Defined and Measured."
Innovation in data analytics and real-world evidence is helping life sciences companies expedite treatment development and uncover new uses for existing treatments.
Premier applauds CMS for addressing several aspects of the Medicare Shared Savings Program (MSSP).
Premier looks forward to evaluating the new requirements aimed at ensuring equal access to emergency services in rural areas.
MedTech Intelligence | Decentralized trials (DCTs) allow for a novel, agile and more cost-effective approach to an industry standard and traditional methodology.